Compositions and methods for the treatment and prevention of vascular malformations
Provided herein are methods and compositions for treating and preventing vascular malformations including lymphatic, venous, capillary, arteriovenous, and combinations thereof. Methods of treatment and prevention include the administration of proteasome inhibitors, omipalisib, disulfiram, and agents which target genes in the PI3K/AKT/mTOR or RAS/RAF/MAPK pathways, including but not limited to Pik3ca, Pik3r3, Tsc2, Rasa1, Map2k2, and Glmn.
1. A method of treating a vascular malformation in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of disulfiram, wherein the vascular malformation is chosen from the group consisting of lymphatic, venous, capillary, and combinations thereof.
2. The method of claim 1 , wherein the disulfiram is administered to the subject by oral administration, parental administration, topical administration, or injection.
3. The method of claim 1 , wherein the subject is under 10 years old.
4. The method of claim 1 , wherein the subject is under 5 years old.
5. The method of claim 1 , wherein the subject is under 1 year old.
6. The method of claim 1 , further comprising, prior to administration, obtaining endothelial cells from the vascular malformation of the subject and testing the efficacy and/or dosage of the disulfiram on endothelial cells obtained from the subject.